Browse
Submit Data
Databases
API
Help

Dataset Information

34 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A Bifunctional Nanosilver-Reduced Graphene Oxide Nanocomposite for Label-Free Electrochemical Immunosensing.

ABSTRACT: A bi-functional material based on silver nanoparticles (AgNPs)-reduced graphene oxide (rGO) composite for both electrode modification and signal generation is successfully synthesized for use in the construction of a label-free electrochemical immunosensor. An AgNPs/rGO nanocomposite is prepared by a one-pot wet chemical process. The AgNPs/rGO composite dispersion is simply cast on a screen-printed carbon electrode (SPCE) to fabricate the electrochemical immunosensor. It possesses a sufficient conductivity/electroreactivity and improves the electrode reactivity of SPCE. Moreover, the material can generate an analytical response due to the formation of immunocomplexes for detection of human immunoglobulin G (IgG), a model biomarker. Based on electrochemical stripping of AgNPs, the material reveals signal amplification without external redox molecules/probes. Under optimized conditions, the square wave voltammetric peak current is responded to the logarithm of IgG concentration in two wide linear ranges from 1 to 50 pg.ml^-1 and 0.05 to 50 ng.ml^-1, and the limit of detection (LOD) is estimated to be 0.86 pg.ml^-1. The proposed immunosensor displays satisfactory sensitivity and selectivity. Importantly, detection of IgG in human serum using the immunosensor shows satisfactory accuracy, suggesting that the immunosensor possesses a huge potential for further development in clinical diagnosis.

SUBMITTER: Chanarsa S

PROVIDER: S-EPMC8113703 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Bio-functionalized graphene-graphene oxide nanocomposite based electrochemical immunosensing.

Project description:We report a novel in-situ electrochemical synthesis approach for the formation of functionalized graphene-graphene oxide (fG-GO) nanocomposite on screen-printed electrodes (SPE). Electrochemically controlled nanocomposite film formation was studied by transmission electron microscopy (TEM) and Raman spectroscopy. Further insight into the nanocomposite has been accomplished by the Fourier transformed infrared spectroscopy (FTIR), thermal gravimetric analysis (TGA) and X-ray diffraction (XRD) spectroscopy. Configured as a highly responsive screen-printed immunosensor, the fG-GO nanocomposite on SPE exhibits electrical and chemical synergies of the nano-hybrid functional construct by combining good electronic properties of functionalized graphene (fG) and the facile chemical functionality of graphene oxide (GO) for compatible bio-interface development using specific anti-diuron antibody. The enhanced electrical properties of nanocomposite biofilm demonstrated a significant increase in electrochemical signal response in a competitive inhibition immunoassay format for diuron detection, promising its potential applicability for ultra-sensitive detection of range of target analytes.

| S-EPMC4193797 | biostudies-literature

A Label-Free Electrochemical Immunosensor for Detection of the Tumor Marker CA242 Based on Reduced Graphene Oxide-Gold-Palladium Nanocomposite.

Project description:As a tumor marker, carbohydrate antigen 24-2 (CA242) is a highly accurate and specific diagnostic indicator for monitoring pancreatic and colorectal cancers. The goal of this study was to create a novel label-free electrochemical immunosensor using a nanocomposite glassy carbon electrode for the detection of CA242. Graphene oxide (GO) and polyvinyl pyrrolidone were chosen as the dopants for the preparation of a high-performance reduced-GO-gold-palladium (rGO-Au-Pd) nanocomposite. RGO-Au-Pd was characterized using X-ray diffraction and transmission electron microscopy, revealing that the material exhibited superior electrochemical redox activity and electron transfer ability. The effects of the synthesis method, material concentration, reduction cycle, and pH were investigated to optimize the performance of the immunosensor. As a result of the catalytic activity and biocompatibility of rGO-Au-Pd, the prepared CA242 immunosensor displayed a wide linear range of detection from 0.001 U/mL to 10,000 U/mL with a detection limit of 1.54 × 10-3 U/mL and a sensitivity of 4.24 ?A (log10CCA242)-1. More importantly, the immunosensor exhibited satisfactory reproducibility and selectivity when detected CA242 in PBS or human serum. The results of our study provide a platform for the development of novel bioassays for use in early cancer diagnosis and promote the application of biosensing technology in the medical field.

| S-EPMC6781068 | biostudies-literature

A label-free immunosensor based on PHEMA/graphene oxide nanocomposite for simultaneous electrochemical determination of alpha fetoprotein.

Project description:An electrochemical immunosensor based on poly(2-hydroxyethyl methacrylate) (PHEMA)/graphene oxide (GO) nanocomposite was designed in a simple way for the ultrasensitive detection of tumor makers (alpha-fetoprotein, AFP as a model). PHEMA with excellent biocompatibility, provides a large number of sites for connecting signal molecules. After modification with signal molecules, the functional PHEMA significantly improved the sensitivity of electrochemical detection. In order to immobilize antibodies, GO was introduced and used to construct a nanocomposite as a substrate. The designed AFP immunosensor showed favorable selectivity and excellent stability. Meanwhile, it has a low detection limit of 0.403 pg mL-1. Furthermore, the immunosensor was used to detect target AFP in human serum, demonstrating the feasibility of clinical diagnosis.

| S-EPMC9064557 | biostudies-literature

Label-Free, Highly Sensitive Electrochemical Aptasensors Using Polymer-Modified Reduced Graphene Oxide for Cardiac Biomarker Detection.

Project description:Acute myocardial infarction (AMI), also recognized as a "heart attack," is one leading cause of death globally, and cardiac myoglobin (cMb), an important cardiac biomarker, is used for the early assessment of AMI. This paper presents an ultrasensitive, label-free electrochemical aptamer-based sensor (aptasensor) for cMb detection using polyethylenimine (PEI)-functionalized reduced graphene oxide (PEI-rGO) thin films. PEI, a cationic polymer, was used as a reducing agent for graphene oxide (GO), providing highly positive charges on the rGO surface and allowing direct immobilization of negatively charged single-strand DNA aptamers against cMb via electrostatic interaction without any linker or coupling chemistry. The presence of cMb was detected on Mb aptamer-modified electrodes using differential pulse voltammetry via measuring the current change due to the direct electron transfer between the electrodes and cMb proteins (Fe3+/Fe2+). The limits of detection were 0.97 pg mL-1 (phosphate-buffered saline) and 2.1 pg mL-1 (10-fold-diluted human serum), with a linear behavior with logarithmic cMb concentration. The specificity and reproducibility of the aptasensors were also examined. This electrochemical aptasensor using polymer-modified rGO shows potential for the early assessment of cMb in point-of-care testing applications.

| S-EPMC7057319 | biostudies-literature

Ag-doped ZnO nanorods embedded reduced graphene oxide nanocomposite for photo-electrochemical applications.

Project description:In this paper, the Ag-doped zinc oxide nanorods embedded reduced graphene oxide (ZnO:Ag/rGO) nanocomposite was synthesized for photocatalytic degradation of methyl orange (MO) in the water. The microstructural results confirmed the successful decoration of Ag-doped ZnO nanorods on rGO matrix. The photocatalytic properties, including photocatalytic degradation, charge transfer kinetics and photocurrent generation, are systematically investigated using electrochemical impedance spectroscopy (EIS), photocurrent transient response (PCTR) and open circuit voltage decay (OCVD). The results of photocatalytic dye degradation measurements indicated that ZnO:Ag/rGO nanocomposite is more effective than pristine ZnO to degrade the MO dye, and the degradation rate reached 40.6% in 30 min. The decomposition of MO with ZnO:Ag/rGO nanostructure followed first-order reaction kinetics with a reaction rate constant (K a) of 0.01746 min-1. The EIS, PCTR and OCVD measurements revealed that the Ag doping and incorporation of rGO could suppress the recombination probability in ZnO by the separation of photo-generated electron-hole pairs, which leads to the enhanced photocurrent generation and photocatalytic activity. The photocurrent density of ZnO:Ag/rGO, ZnO/rGO and pristine ZnO are 206, 121.4 and 88.8 nA cm-2, respectively.

| S-EPMC6408384 | biostudies-literature

A label-free biosensor based on graphene and reduced graphene oxide dual-layer for electrochemical determination of beta-amyloid biomarkers.

Project description:A label-free biosensor is developed for the determination of plasma-based A?1-42 biomarker in Alzheimer's disease (AD). The platform is based on highly conductive dual-layer of graphene and electrochemically reduced graphene oxide (rGO). The modification of dual-layer with 1-pyrenebutyric acid N-hydroxysuccinimide ester (Pyr-NHS) is achieved to facilitate immobilization of H31L21 antibody. The effect of these modifications were studied with morphological, spectral and electrochemical techniques. The response of the biosensor was evaluated using differential pulse voltammetry (DPV). The data was acquired at a working potential of ~?180 mV and a scan rate of 50 mV s-1. A low limit of detection (LOD) of 2.398 pM is achieved over a wide linear range from 11 pM to 55 nM. The biosensor exhibits excellent specificity over A?1-40 and ApoE ?4 interfering species. Thus, it provides a viable tool for electrochemical determination of A?1-42. Spiked human and mice plasmas were used for the successful validation of the sensing platform in bio-fluidic samples. The results obtained from mice plasma analysis concurred with the immunohistochemistry (IHC) and magnetic resonance imaging (MRI) data obtained from brain analysis. Graphical abstract Schematic representation of the electrochemical system proposed for A?1-42 determination: (a) modification of graphene screen-printed electrode (SPE) with monolayer graphene oxide (GO) followed by its electrochemical reduction generating graphene/reduced graphene oxide (rGO) dual-layer (b), modification of dual-layer with linker (c), A?1-42 antibody (H31L21) (d), bovine serum albumin (BSA) (e) and A?1-42 peptide (f).

| S-EPMC7182627 | biostudies-literature

Thermally reduced mesoporous manganese MOF @reduced graphene oxide nanocomposite as bifunctional electrocatalyst for oxygen reduction and evolution.

Project description:Oxygen electrocatalysis plays a crucial role in harnessing energy from modern renewable energy technologies like fuel cells and metal-air batteries. But high cost and stability issues of noble metal catalysts call for research on tailoring novel metal-organic framework (MOF) based architectures which can bifunctionally catalyze O2 reduction and evolution reactions (ORR & OER). In this work, we report a novel manganese MOF @rGO nanocomposite synthesized using a facile self-templated solvothermal method. The nanocomposite is superior to commercial Pt/C catalyst both in material resource and effectiveness in application. A more positive cathodic peak (E pc = 0.78 V vs. RHE), onset (E onset = 1.09 V vs. RHE) and half wave potentials (E 1/2 = 0.98 V vs. RHE) for the ORR and notable potential to achieve the threshold current density (E @10 mA cm-2 = 1.84 V vs. RHE) for OER are features promising to reduce overpotentials during ORR and OER. Small Tafel slopes, methanol tolerance and acceptable short term stability augment the electrocatalytic properties of the as-prepared nanocomposite. Remarkable electrocatalytic features are attributed to the synergistic effect from the mesoporous 3D framework and transition metal-organic composition. Template directed growth, tunable porosities, novel architecture and excellent electrocatalytic performance of the manganese MOF @rGO nanocomposite make it an excellent candidate for energy applications.

| S-EPMC9055589 | biostudies-literature

Carbon Black and Reduced Graphene Oxide Nanocomposite for Binder-Free Supercapacitors with Reduced Graphene Oxide Paper as the Current Collector.

Project description:Reduced graphene oxide (rGO) is an ideal candidate for the improvement of supercapacitor (SC) performances due to its industrial-ready manufacturing process and ease of processing. In this work, rGO was used as an active binder for the manufacture of carbon black (CB) and rGO-based SCs. Being able to form a stable suspension in water, graphene oxide (GO) was initially exploited as a dispersing agent to fabricate a homogeneous slurry with CB having exclusively water as a low-cost and environment-friendly solvent. After casting on a suitable substrate, the material was subjected to thermal treatment allowing the reduction of GO to rGO, which was successively confirmed by chemical-physical analysis. An innovative current collector, consisting of high-quality rGO paper, was also proposed ensuring an improved adhesion between the active material and the substrate and a reduction of the whole weight with respect to devices fabricated using common metallic current collectors. Due to the interesting electrochemical performances, with a high specific power of 32.1 kW kg-1 and a corresponding specific energy of 8.8 Wh kg-1 at a current of 1 A g-1, and the improved manufacturing process, the described "all-graphene-based" device represents a valuable candidate for the future of SCs.

| S-EPMC7758981 | biostudies-literature

A reduced graphene oxide-β-cyclodextrin nanocomposite-based electrode for electrochemical detection of curcumin.

Project description:Curcumin is a polyphenolic compound with anti-oxidative and anti-cancer properties that is obtained from turmeric plants. Several studies have demonstrated that cancer cells are not killed unless they are exposed to 5-50 mM of curcumin. Consequently, it is vital to control the concentration of curcumin in cancer therapy. In this study, a sensitive electrochemical sensor was fabricated based on a beta-cyclodextrin-reduced graphene oxide (β-CD-rGO) nanocomposite for measuring curcumin concentration. The effects of experimental factors were investigated and the optimum parametric conditions were determined using the Taguchi optimization method. The β-CD-rGO modified electrode exhibited good electrochemical properties for curcumin detection. The results of differential pulse voltammetry experiments unveiled that the sensor shows a linear response to curcumin concentration over the range of 0.05-10 mM with a detection limit of 33 nM and sensitivity of 4.813 μA μM-1. The fabricated sensor exhibited selectivity in the presence of other electroactive species, e.g., propranolol, clomipramine and clonazepam.

| S-EPMC8695096 | biostudies-literature

Label-free Detection of Influenza Viruses using a Reduced Graphene Oxide-based Electrochemical Immunosensor Integrated with a Microfluidic Platform.

Project description:Reduced graphene oxide (RGO) has recently gained considerable attention for use in electrochemical biosensing applications due to its outstanding conducting properties and large surface area. This report presents a novel microfluidic chip integrated with an RGO-based electrochemical immunosensor for label-free detection of an influenza virus, H1N1. Three microelectrodes were fabricated on a glass substrate using the photolithographic technique, and the working electrode was functionalized using RGO and monoclonal antibodies specific to the virus. These chips were integrated with polydimethylsiloxane microchannels. Structural and morphological characterizations were performed using X-ray photoelectron spectroscopy and scanning electron microscopy. Electrochemical studies revealed good selectivity and an enhanced detection limit of 0.5 PFU mL-1, where the chronoamperometric current increased linearly with H1N1 virus concentration within the range of 1 to 104 PFU mL-1 (R2 = 0.99). This microfluidic immunosensor can provide a promising platform for effective detection of biomolecules using minute samples.

| S-EPMC5309888 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data